Ambispective Multicentric Study Evaluating UKA With U-Knee/Uni-Kroma Implants
- Conditions
- Unicompartmental Knee Arthroplasty
- Registration Number
- NCT05876143
- Lead Sponsor
- Societe dEtude, de Recherche et de Fabrication
- Brief Summary
This clinical investigation was led as a post-market clinical follow-up study (post-market device development stage).The main objective of this study is to collect short- and medium-term clinical data on the unicondylar knee prosthesis U-Knee / Uni-Kroma, in order to evaluate the performance of these implants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
- All patients using a U-Knee / Uni-Kroma unicompartmental knee prosthesis and benefiting from the social security affiliation scheme.
- Patients who objected to participating in the study and the processing of their data
- Patients unable to understand the surgeon's instructions to complete their questionnaires or perform postoperative follow-up
- Patients who already have a unicompartmental prosthesis on the knee in question that need to be revised.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival rate 5 years Assess the survival rate of the investigational medical devices at 5 year follow-up
- Secondary Outcome Measures
Name Time Method Functional improvement From pre-operative to 10 years Evaluate pain, symptoms, activities of daily life and sports activity using KOOS score
Activity From pre-operative to 10 years Evaluate the degree of activity using Devane score
Survival rate 12-18 months to 10 years Assess the survival rate of the investigational medical devices at 12-18 months, 3 years and 10 years follow-up
Forgetfulness of prosthesis From pre-operative to 10 years Evaluate the degree of forgetfulness of the prostheses using FJS- score
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU Lyon Sud
🇫🇷Pierre-Bénite, France
CHU Lyon Sud🇫🇷Pierre-Bénite, FranceAnthony VisteContact